【24h】

Laparoscopic surgery for rectal cancer: outcomes in 513 patients.

机译:腹腔镜手术治疗直肠癌:513例患者的预后。

获取原文
获取原文并翻译 | 示例
           

摘要

Few reports have demonstrated the feasibility and efficacy of laparoscopic resection in patients with rectal cancer (RC). The objective of the present study was to assess the effectiveness of laparoscopic resection for RC, with an emphasis on perioperative variables and long-term oncological outcomes.This prospective study was carried out between January 2005 and September 2010 and included 513 patients diagnosed with RC who underwent laparoscopic surgery. Patients with locally advanced RC (cT3/cT4 or N+) received neoadjuvant treatment. Adjuvant treatment was applied to patients with stage II/III disease or according to the neoadjuvant protocol. All patients were followed-up prospectively for the evaluation of complications and oncological outcome. Survival rate analysis was performed using the Kaplan-Meier method.Sphincter-preserving surgery was performed on 389 patients, and the remaining 124 patients underwent abdominoperineal resection. Perioperative mortality occurred in only one patient (0.2 %), and 27 (5.3 %) intraoperative complications were recorded. The most common postoperative complication was anastomotic leakage (5.5 %). The conversion rate was 6.4 %. The mean number of harvested lymph nodes was 23.6 ± 13. The mean distance to the distal margin was 2.6 ± 1.9 (0-7) cm. Distal margin positivity was detected in 9 (1.7 %) patients. The circumferential margin was positive in 39 (7.6 %) cases. After a median follow-up period of 30 (1-78) months, recurrence occurred in a total of 59 patients (11.5 %). Local recurrence was detected in 16 patients (3.1 %), and both local and distant recurrence was found in 7 patients (1.4 %). Distant recurrence only was detected in 43 patients (8.4 %). The overall 5-year survival rate was 84 %, and the 5-year disease-free survival rate was 77.4 %. The local recurrence-free survival rate was 98.4 % at 2 years, 95.7 % at 3 years, and 94.3 % at 5 years.Our results, together with the review of the literature, clearly demonstrate that laparoscopic resection for RC is a feasible method at specialized high-volume centers. The long-term outcomes are at least as good as those from open surgery as long as the principles of oncologic surgery are respected and faithfully performed.
机译:很少有报道证明腹腔镜切除术可治疗直肠癌(RC)患者。本研究的目的是评估腹腔镜切除术对RC的有效性,重点是围手术期变量和长期肿瘤学结果。这项前瞻性研究于2005年1月至2010年9月进行,纳入了513例诊断为RC的患者进行了腹腔镜手术。局部晚期RC(cT3 / cT4或N +)患者接受新辅助治疗。对患有II / III期疾病或根据新辅助方案的患者进行了辅助治疗。对所有患者进行前瞻性随访,以评估并发症和肿瘤学结局。使用Kaplan-Meier方法进行生存率分析,对389例患者进行了保留括约肌的手术,其余124例患者接受了腹部手术切除。仅一名患者(0.2%)发生了围手术期死亡率,并且记录了27例(5.3%)术中并发症。术后最常见的并发症是吻合口漏(5.5%)。转化率为6.4%。收集到的淋巴结平均数为23.6±13。到远端边缘的平均距离为2.6±1.9(0-7)cm。在9名(1.7%)患者中检测到远端切缘阳性。 39例(7.6%)病例的周缘边缘为阳性。在中位随访期30(1-78)个月后,共有59例患者(11.5%)复发。在16例患者中发现了局部复发(3.1%),在7例患者中发现了局部和远处复发(1.4%)。仅43例患者(8.4%)检出远处复发。总体5年生存率为84%,5年无病生存率为77.4%。 2年时局部无复发生存率为98.4%,3年时为95.7%,5年时为94.3%。我们的结果以及文献综述清楚地表明,腹腔镜切除RC是一种可行的方法。专业的高容量中心。只要尊重并忠实执行肿瘤外科手术的原则,长期结果至少与开放手术的结果一样好。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号